Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

The prescribed dosage for Genotropin (somatropin) may depend on your condition and your treatment plan. Doctors may base some dosages of the drug on body weight. Genotropin (somatropin ...

See the dosage table in the “Briumvi dosage for certain forms of MS” section, which describes how many weeks apart you’ll receive infusions. The active ingredient in Briumvi is ublituximab-xiiy.

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

In the past two years, the Food and Drug Administration has approved two novel Alzheimer's therapies, based on data from ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

A small study of Sanofi’s lixisenatide has suggested that the GLP-1 agonist could slow down the progression of Parkinson’s disease, pointing to another potential use for the fast-growing drug ...

The FDA has approved the sBLA for once every 4 weeks lecanemab-irmb (Leqembi®) intravenous maintenance dosing.

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

Objective—Recent data suggested that sex hormone–binding globulin (SHBG) levels decrease when fat accumulates in the liver and that circulating SHBG may be causally involved in the ...